Article info
Review
British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Correspondence to Dr Marie-Helene Marion, London BTX Centre, 9a Wilbraham Place Practice, London SW1X 9AE, UK; mariehelenemarion{at}gmail.com
Citation
British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
Publication history
- Accepted February 17, 2016
- First published March 14, 2016.
Online issue publication
July 14, 2016
Article Versions
- Previous version (14 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia
- Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases
- Symptomatic and functional outcome of surgical treatment of cervical dystonia
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- Selective peripheral denervation for cervical dystonia: long-term follow-up
- Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study
- Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
- Interhemispheric difference of pallidal local field potential activity in cervical dystonia
- Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®